Department of Psychiatry and Behavioral Sciences

The Einstein Department of Psychiatry and Behavioral Science's training programs offer unparalleled dedication to professional growth and personal development. Founded on the tenets of academic excellence, personal diversity, and individual attention, they are designed to help trainees actualize their being and becoming, as all technical and professional skills are, ultimately, contextually tailored manifestations of one's self.

Programs

Psychiatry Residency Program
The Montefiore/Einstein Psychiatry Residency Program prepares trainees to become excellent clinicians, able to integrate biological, psychodynamic, phenomenological and socio-cultural models in the effective treatment of patients. program website 

Fellowship Programs
Einstein/Montefiore Psychology Fellowship Programs offer ACGME-accredited professional development opportunities in child/adolescent psychiatry, addiction psychiatry, geriatric psychiatry, forensic psychiatry, and psychosomatic medicine. fellowship website 

Psychology Internship Program
The Einstein/Montefiore Psychology Internship Training Program is an APA-accredited, year-long predoctoral internship with an established reputation for providing exceptional training opportunities for future psychologists. more info 

Medical Student Clerkship
The six-week psychiatry clerkship trains medical students to evaluate patients under the clinical care of psychiatrists and to integrate the mental status examination into general clinical care.

Upcoming Events

47th Annual Leadership Conference 

Date: May 31 - June 2, 2019
Brochure 2019 

 

Calendar

Wednesday, April 21, 2021 | 3:00 PM
Optimizing Commercial Value of Intellectual Property
https://einsteinmed.zoom.us/meeting/register/tJAlc, Virtual

Thursday, April 22, 2021 | 7:45 AM
The 2021 Isabelle Rapin Lecture by Dr. Huda Zoghbi
via zoom, n/a

view calendar

 

Media Spotlight

New Drugs That Block a Brain Chemical Are Game Changers for Some Migraine Sufferers

Richard Lipton, M.D., discusses the use of a newer class of migraine drugs known as gepants, which target a neurotransmitter implicated in migraine. Dr. Lipton is Edwin S. Lowe Professor and vice chair of the Saul R. Korey Department of Neurology at Einstein, and director of the Montefiore Headache Center.

(Sunday, Mar 28, 2021)

coverage on other stories

 
Click here to log in